Meet Pharmidex at FIP Buenos Aires 2016!
August 28, 2016
Pharmidex will be In Argentina for FIP 2016 between the 28th of August to the 1st of September
Meet Pharmidex at FIP Buenos Aires 2016!
Meet Pharmidex at FIP Buenos Aires 2016 between the 28th of August and 1st of September.
Pharmidex will be represented by our MD Mo Alavijeh and John Bakker our director of HR and OD. During the 2016 FIP Congress in Buenos Aires, Argentina pharmacists and pharmaceutical scientists will rise to the challenge to reduce the global disease burden.
For more information please see:
http://buenosaires2016.fip.org/
We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist
We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩🔬 👨🔬 Welcome to the team, Gabrielle and Mohammed!
At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.
